69 Best Health Tech Startups in Cambridge to Watch in 2025

The Definitive Seedtable Ranking of Health Tech Startups in Cambridge

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 105 start-ups with an aggregate funding of $5.3b. The average funding per company in this subset is $76.8m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

4

Funding Rounds

$6.5m

Money raised

A digital fertility clinic offering semen analysis, sperm improvement, and sperm cryostorage services. Founded at Harvard in 2018, the company has raised $20M from investors like Y Combinator, Bain Capital Ventures, FirstMark Capital, and celebrities like Justin Bieber.

Key people:

3

Funding Rounds

$60.0m

Money raised

Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.

Key people:

4

Funding Rounds

$49.3m

Money raised

Sphere Fluidics is a company commercializing single cell analysis systems founded in 2010 by Wilhelm Huck.

5

Funding Rounds

$10.1m

Money raised

A full-stack neural interface company. BIOS is creating a hardware and software interface between the human nervous system and AI with the aim of developing AI-based neural treatments that recreate neural signal patterns capable of affecting the health of a person.

3

Funding Rounds

$183.9m

Money raised

Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.

8

Funding Rounds

$160.3m

Money raised

Breathalyzer device maker for the early detection of cancer.

Key people:

3

Funding Rounds

$133.0m

Money raised

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Key people:

5

Funding Rounds

$30.9m

Money raised

Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services

Key people:

10

Funding Rounds

$62.4m

Money raised

A software solutions company providing bioinformatics solutions to life science and other sector

6

Funding Rounds

$2.4m

Money raised

A company that has developed software for easier access to genomic data. It is located in Cambridge, England and was founded in 2015.

Key people:

5

Funding Rounds

$65.4m

Money raised

An agricultural biotechnology company producing renewable, biomass-based fuels and raw materials

11

Funding Rounds

$1.4b

Money raised

CMR Surgical is a surgical robotics solutions provider founded in 2014 by Martin Frost, Luke Hares and Mark Slack.

Key people:

4

Funding Rounds

$124.1m

Money raised

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Key people:

5

Funding Rounds

$187.0m

Money raised

Iterative Health is a Cambridge, Massachusetts-based company that provides gastroenterologists with machine learning-powered diagnostic tools to aid in the prevention of colon cancer and improve patient outcomes.

4

Funding Rounds

$68.1m

Money raised

Evonetix is a synthetic biology company

Key people:

8

Funding Rounds

$84.5m

Money raised

Mogrify is developing tailored cellular conversions that power future cell therapies.

1

Funding Rounds

Isomerase is a Cambridge based microbial natural products drug discovery and development CRO and synthetic biology, fermentation and chemistry service provider

13

Funding Rounds

$123.5m

Money raised

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.

6

Funding Rounds

$52.4m

Money raised

Endomag is an Austin, Texas-based medical diagnostics company developing detection technology for lymphatic cancers.

4

Funding Rounds

$179.4m

Money raised

Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.

4

Funding Rounds

$420.2m

Money raised

Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells

1

Funding Rounds

$24.0m

Money raised

Ieso Digital Health is a Cambridge, Cambridgeshire-based digital health company offering internet enabled evidence-based psychological therapies.

3

Funding Rounds

$66.0m

Money raised

Mori manufactures an all-natural protective layer to slow down the spoiling process of food.

9

Funding Rounds

$110.7m

Money raised

Congenica clinical decision support software is the world's leading solution for the analysis of genomic data, enabling healthcare professionals globally.

Key people:

6

Funding Rounds

$29.6m

Money raised

AI platform to advance precision medicine clinical trials.

Key people:

4

Funding Rounds

$76.8m

Money raised

Provider of SITESEEKER platform for discovering new drugs.

1

Funding Rounds

$1.1m

Money raised

Software allowing hospitals to offer personal health records for better patient self-management.

5

Funding Rounds

$10.5m

Money raised

Definigen is a human Cell Models of Rare Diseases founded in 2012 by Marcus Yeo.

3

Funding Rounds

$77.0m

Money raised

PetMedix is a veterinary therapeutics biotechnology company based in Cambridge, UK. working to develop precision therapeutics to improve the health and welfare of pets.

5

Funding Rounds

$55.9m

Money raised

MetaMark Genetics is a medical diagnostics company developing tests and treatment planning for cancer patients.

5

Funding Rounds

$94.3m

Money raised

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

2

Funding Rounds

$26.0m

Money raised

Developer of VR powered cognitive treatments intended to deliver psychological treatments.

3

Funding Rounds

$115.0m

Money raised

Platform for AI-driven drug discovery in clinical-stage development.

Key people:

4

Funding Rounds

$101.6m

Money raised

Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer

2

Funding Rounds

$20.0m

Money raised

A company that provides services and technologies for the development and commercialization of biopharmaceutical products

4

Funding Rounds

$166.8m

Money raised

Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.

4

Funding Rounds

$53.0m

Money raised

Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.

4

Funding Rounds

$22.5m

Money raised

Cambridge-based Genomics Company specializing in DNA sequencing technology

1

Funding Rounds

$40.6m

Money raised

Therapies designed to achieve long-term disease remission with less frequent doses.

10

Funding Rounds

$27.8m

Money raised

A Cambridge UK based company focused on the development of technologies for single-molecule analysis

Key people:

4

Funding Rounds

$58.3m

Money raised

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

3

Funding Rounds

$88.0m

Money raised

Foldrx Pharmaceuticals is a company that develops disease modifying drug therapies.

1

Funding Rounds

$718.0k

Money raised

A company offering medicinal chemistry and computational chemistry services for drug dicovery

3

Funding Rounds

$70.0m

Money raised

Biofidelity Ltd is a genetic Testing Technology founded in 2019 by Barnaby Balmforth.

Key people:

1

Funding Rounds

$1.6m

Money raised

Abcodia is a Cambridge, Cambridgeshire-based biotechnology company developing and validating molecular biomarkers for early cancer detection and other applications.

Key people:

2

Funding Rounds

$8.2m

Money raised

CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.

Key people:

2

Funding Rounds

$19.1m

Money raised

PredictImmune is a Cambridge, Cambridgeshire-based medical diagnostics company developing diagnostic products for addressing inflammatory bowel diseases.

1

Funding Rounds

$88.0m

Money raised

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Key people:

3

Funding Rounds

$37.2m

Money raised

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

Key people:

4

Funding Rounds

$23.2m

Money raised

Platform for increasing protein production in the body using specialized translation enhancers.

2

Funding Rounds

$11.0m

Money raised

Xampla is a Cambridge, Cambridgeshire-based company founded in 2018 by Tuomas Knowles.

2

Funding Rounds

$2.9m

Money raised

Platform utilizing microfabrication technology to create smart materials for innovative cell testing.

Key people:

1

Funding Rounds

$600.0k

Money raised

Xenomics is advancing breakthroughs in genetics and biomanufacturing to combat major sustainability issues in food, energy, and health.

1

Funding Rounds

$3.5m

Money raised

Clinical Research IO is a clinical research company founded in 2015 by Phuc Truong.

2

Funding Rounds

$19.5m

Money raised

Resolvyx Pharmaceuticals is a company developing small molecule therapeutics for the treatment of inflammatory diseases

Key people:

1

Funding Rounds

$9.1m

Money raised

Supplant is a Cambridge, Cambridgeshire-based company founded in 2017 by Ruben Tadmor.

Key people:

1

Funding Rounds

Intellegens is an artificial Intelligence company founded by Ben Pellegrini.

2

Funding Rounds

$40.4m

Money raised

Wren Therapeutics is a small Molecules Targeting Protein Mis-Folding founded in 2016 by Chris Dobson.

1

Funding Rounds

$16.0m

Money raised

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

Key people:

2

Funding Rounds

$20.0m

Money raised

Charco Neurotech is a wearable device that offers non-invasive medical technology founded in 2019.

3

Funding Rounds

$60.0m

Money raised

A biotechnology company developing therapies and personalized diagnostics for celiac disease

2

Funding Rounds

$88.0m

Money raised

Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.

Key people:

1

Funding Rounds

$4.2m

Money raised

Axol Bioscience Ltd is a human Cell Culture Products founded in 2012.

4

Funding Rounds

$47.8m

Money raised

NeoPhore is a small Molecules founded in 2017.

2

Funding Rounds

$7.5m

Money raised

Contract Research Organization specializing in bioscience research services.

Software solutions for small molecule design, optimization and data analysis

1

Funding Rounds

$8.0m

Money raised

PlaqueTec is developing a Liquid Biopsy System, for the prevention, diagnosis and treatment of coronary artery disease.

1

Funding Rounds

$22.0m

Money raised

A biopharmaceutical company developing drugs to treat pain, inflammation, anxiety and other diseases

1

Funding Rounds

$50.0m

Money raised

Transition Bio is a condensate technology, liquid-liquid phase separation founded by Peter St George-Hyslop.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.